Figure 2From: Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology GroupOverall survival of 69 patients treated with paclitaxel/carboplatin for early-stage (FIGO stages I-IIb) ovarian carcinoma.Back to article page